Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).
- DOI
- 10.1016/j.esmoop.2021.100277
- Published
- 2021 Oct
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2021.100277,
title = {Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).},
author = {Tanaka Y and Takeuchi H and Nakashima Y and Nagano H and Ueno T and Tomizuka K and Morita S and Emi Y and Hamai Y and Hihara J and Saeki H and Oki E and Kunisaki C and Otsuji E and Baba H and Matsubara H and Maehara Y and Kitagawa Y and Yoshida K},
year = {2021},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2021.100277},
url = {https://doi.org/10.1016/j.esmoop.2021.100277}
}RIS
TY - JOUR TI - Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5). AU - Tanaka Y AU - Takeuchi H AU - Nakashima Y AU - Nagano H AU - Ueno T AU - Tomizuka K AU - Morita S AU - Emi Y AU - Hamai Y AU - Hihara J AU - Saeki H AU - Oki E AU - Kunisaki C AU - Otsuji E AU - Baba H AU - Matsubara H AU - Maehara Y AU - Kitagawa Y AU - Yoshida K PY - 2021 JO - ESMO open DO - 10.1016/j.esmoop.2021.100277 UR - https://doi.org/10.1016/j.esmoop.2021.100277 ER -
APA
Y, T., H, T., Y, N., H, N., T, U., K, T., S, M., Y, E., Y, H., J, H., H, S., E, O., C, K., E, O., H, B., H, M., Y, M., Y, K., & K, Y. (2021). Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).. ESMO open. https://doi.org/10.1016/j.esmoop.2021.100277
Source records
- pubmed · retrieved 2026-09-26T23:33:39.122Z